Literature DB >> 2589101

Why do fatal overdose rates vary between antidepressants?

R D Farmer1, R M Pinder.   

Abstract

Age specific death rates for poisoning with different antidepressant drugs, based on mortality statistics and the numbers of prescriptions dispensed, were calculated for England and Wales 1979-1985. There are marked variations in mortality associated with different drugs; the highest rates are found with amitriptyline and dothiepin whereas the lowest were associated with mianserin and clomipramine. For all drugs considered, the calculated mortality rates for the over 65 year olds, though still substantial, were lower than those in patients under 65 years of age, probably because of a diminished detection rate of poisoning in this older age group. A high proportion of the fatal overdoses implicating amitriptyline and dothiepin involved more than one substance. The rank order of mortality rates from antidepressants was identical in the different age groups. The implications of these findings are discussed. It is concluded that the variations in mortality rates are mostly due to variations in the inherent toxicity of the drugs (particularly their cardiovascular effects) and only in part due to possible differences in compliance. It is suggested that when antidepressant drugs are prescribed, the risk of death from overdose should be taken into account. Tricyclic drugs, particularly amitriptyline, dothiepin, doxepin, trimipramine and maprotiline, should be avoided in patients at risk of suicide, whatever the age of the patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589101     DOI: 10.1111/j.1600-0447.1989.tb03044.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  11 in total

1.  Suicidal antidepressant overdoses: a comparative analysis by antidepressant type.

Authors:  Nicole White; Toby Litovitz; Cathleen Clancy
Journal:  J Med Toxicol       Date:  2008-12

Review 2.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

3.  Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.

Authors:  D A Revicki; C S Palmer; S D Phillips; J A Reblando; J H Heiligenstein; J Brent; K Kulig
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

Review 4.  Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-01       Impact factor: 5.270

5.  Antidepressants and suicide. Study is based on unproved assumptions.

Authors:  A House; T Sheldon; N Freemantle
Journal:  BMJ       Date:  1995-07-01

6.  Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.

Authors:  N Freemantle; A House; F Song; J M Mason; T A Sheldon
Journal:  BMJ       Date:  1994-07-23

Review 7.  Prevention of suicide: aspirations and evidence.

Authors:  D Gunnell; S Frankel
Journal:  BMJ       Date:  1994-05-07

Review 8.  Epidemiology and relative toxicity of antidepressant drugs in overdose.

Authors:  J A Henry
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 9.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

Review 10.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.